Apeloa Pharmaceutical concludes share repurchase program for equity incentive plans

Apeloa Pharmaceutical Co., Ltd. has completed its share repurchase program, which ran from April 30, 2025, to November 12, 2025. The company repurchased a total of 10,442,300 shares, representing 0.90% of its current total share capital. The maximum transaction price was CNY15.59 per share, and the minimum was CNY13.62 per share.

The total transaction value for the repurchase was CNY149,981,053 (excluding transaction fees), with total funds utilized amounting to CNY149,997,560.64 (including transaction fees). The funds came from the company's own capital and financial institution borrowings. The repurchased shares are intended for equity incentive or employee stock ownership plans.

Should the company fail to utilize the repurchased shares for their intended purpose within 36 months, any unutilized portion will be canceled in accordance with legal procedures. This repurchase is not expected to significantly impact the company's financial health, operations, or ownership structure.